Retatrutide × Elutide - Lab Test, June 2026
ILS Laboratories publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
Test results
About this test
This independent HPLC lab test confirms Retatrutide 50mg from Elutide at 98.69% purity with 52.49mg tested content. The analysis was conducted by ILS Laboratories on June 8, 2026.
Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist researched for its potential in weight management, metabolic regulation, and enhanced glucose control through multi-pathway appetite suppression and improved insulin sensitivity. A purity level of 98.69% indicates minimal impurities and high-grade synthesis.
Heavy metals analysis (ICP-MS) shows no detection of arsenic, cadmium, chromium, mercury, or lead, confirming safety profile. The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion
No comments yet. Sign in to be the first to discuss this test.